Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthéra))and General Corticotherapy Treatment in Patients With Pemphigus
Phase of Trial: Phase III
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Rituximab (Primary) ; Corticosteroids
- Indications Pemphigus
- Focus Therapeutic Use
- 13 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Mar 2017 New trial record
- 24 Mar 2017 According to a Roche media release, results of the study have been published in The Lancet.